Literature DB >> 760500

Clindamycin-induced colitis.

R Fekety, J Silva, R A Browne, G D Rifkin, J R Ebright.   

Abstract

The hamster model of enterocolitis after the administration of clindamycin was used to study various drugs used in treatment of the disease in humans. Current evidence strongly suggests toxigenic, clindamycin-resistant Clostridium difficile is a cause of the disease in hamster and man. This organism is susceptible to vancomycin and metronidazole, and the disease could be prevented in the hamster so long as the antibiotics were given orally. A fatal colitis almost invariably ensued once they were discontinued. Administration of cholestyramine significantly prolonged survival of hamsters, but did not pervent death or colitis. Corticosteroids or atropine-diphenoxylate (Lomotil) did not alter the disease. The hamster model may be useful in studying other kinds of treatment of this disease.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 760500     DOI: 10.1093/ajcn/32.1.244

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  7 in total

1.  Factors associated with length of stay in hospital for suspected community-acquired pneumonia.

Authors:  Jane Q Huang; Peter M Hooper; Thomas J Marrie
Journal:  Can Respir J       Date:  2006-09       Impact factor: 2.409

2.  Purification and characterization of toxins A and B of Clostridium difficile.

Authors:  N M Sullivan; S Pellett; T D Wilkins
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

3.  Suppression of Clostridium difficile in the gastrointestinal tracts of germfree mice inoculated with a murine isolate from the family Lachnospiraceae.

Authors:  Angela E Reeves; Mark J Koenigsknecht; Ingrid L Bergin; Vincent B Young
Journal:  Infect Immun       Date:  2012-08-13       Impact factor: 3.441

Review 4.  Models for the study of Clostridium difficile infection.

Authors:  Emma L Best; Jane Freeman; Mark H Wilcox
Journal:  Gut Microbes       Date:  2012-03-01

Review 5.  Clostridium difficile: clinical disease and diagnosis.

Authors:  F C Knoop; M Owens; I C Crocker
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

6.  Metabolism of bile salts in mice influences spore germination in Clostridium difficile.

Authors:  Jennifer L Giel; Joseph A Sorg; Abraham L Sonenshein; Jun Zhu
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

Review 7.  Hype or hypervirulence: a reflection on problematic C. difficile strains.

Authors:  Wiep Klaas Smits
Journal:  Virulence       Date:  2013-09-10       Impact factor: 5.882

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.